/ Press Releases- 2014.06
- TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 in United States.
- 2014.06
- Twi Pharmaceuticals, Inc. announces the acquisition of Hainan Visum Pharmaceutical Co., Ltd in China, starting the new chapter of international mergers and acquisitions.
- 2014.04
- TWi Announces Settlement of Lidoderm® Patent Litigation
- 2014.04
- TWi Announces ANDA Approval of Generic Procardia XL® Tablets 30 mg, 60 mg and 90mg in the United States
- 2014.02
- TWi Pharmaceuticals Confirms Favorable Ruling in Generic MEGACE ES® Patent Suit
- 2013.10
- TWi Pharmaceuticals, Inc. Comments on Dexilant® Ruling
- 2013.07
- TWi Pharmaceuticals Receives Patent Allowance for Its Reduced Food Effect Metformin Controlled Release Formulation in United States
- 2013.06
- TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201
- 2013.05
- TWi Pharmaceuticals Announces Tentative ANDA Approval for Guanfacine Hydrochloride Extended-Release Tablets